While our previous studies have shown that ERα and PgR positive tumours were seen at a similar frequency across all BRCA1, BRCA2 and BRCAX cohorts and more commonly than in FBC [1], based on this genotypic analysis, the mechanism and effect of PIK3CA mutation is likely to be different between the subgroups. This evidence concerns the gene PIK3CA and neoplasm.